OUR HISTORY
Bio-Modeling Systems is founded
by Dr. Iris, M. Gea and Dr. Dine
Participation in 2 French nation-wide projects; profitable ever since
2004
2006
-
Development of the CADI™ analytical platform.
-
Four new models completed (FGF4-driven fibroblast differentiation, hypercholesterolemia, Chronic Fatigue Syndrome, Creutzfeldt Jakob disease) two of which are undergoing independent biological evaluation.
-
Synthons White Biotechnology
-
Bio-Defense and Bio-Security
Invention of 3 proprietary technologies
TAPE, RipH, AbACCUS
allowing the production of phage banks capable of targeting any known or yet unknown bacteria
2008
Patent covering new therapeutic strategies and creation of a preclinical evaluation platform in the field of psychiatric disorders.
2010
Pherecydes Pharma S.A. spin-off (anti-bacterial bio-agents) incorporation
- Bio-IT World Best Practices Award from the Cambridge Healthtech Institute
- State-of-the-Art of Systems Biology applications in Medicine award; European Commission DG 2010
Computational Biophysics of the Skin book publication
2012
CEA /BMSystems collaborative research in CNS (Psychiatric and Neurological disorders) led to the co-owned patent WO201029131 with a worldwide exclusive license to Theranexus CEA’s spin-off.
First CADI models (v.0) for Neurodegenerative Diseases
2014
-
Parkinson's Disease
-
Alzheimer's Disease
Psychiatric Diseases & Microbiota
2016
Metabolic Disorders & Child Malnutrition
2018
-
Autism Spectrum Disorders (ASD)
-
Bipolar disorder
-
Schizophrenia
-
Depression
-
ADHD
Indian National Program for child
-
Stunting
-
Wasting
Therapeutic Protocol for Low-Grade Inflammatory Diseases
2020
-
Chronic Fatigue Syndrome/ ME
-
Gulf War Syndrome
GEMMA H2020 14,2 M€ project on
ASD - Microbota Interactions